China Medical GatewayLoading your healthcare gateway…

Zhang Qian

Zhang Qian — Chief Physician — Urology — Peking University First Hospital

Specialties

Da Vinci robot-assisted laparoscopic nerve-sparing radical prostatectomy for prostate cancer; high-difficulty laparoscopic partial nephrectomy preserving renal units, laparoscopic resection of large renal cancers, laparoscopic minimally invasive treatment of renal cancer with tumor thrombus, laparoscopic radical cystectomy, and other laparoscopic minimally invasive treatments.

Professional Experience

Chief Physician of the Department of Urology at Peking University First Hospital, professor, and doctoral supervisor; currently serves as the Director of Beijing Shijitan Hospital affiliated with Capital Medical University, and Deputy Director of the Institute of Urology at Peking University. With more than twenty years of medical practice, he has accumulated extensive experience in the diagnosis and treatment of urinary system tumors. He is skilled in Da Vinci robotic radical prostatectomy, laparoscopic minimally invasive surgery (including three-port laparoscopic radical prostatectomy, high-difficulty laparoscopic partial nephrectomy, laparoscopic resection of renal tumor thrombus, radical cystectomy, etc.), with more than 5,000 laparoscopic surgeries performed. He has achieved multiple innovations in the field of laparoscopy at an internationally advanced level and has been invited to assist in surgeries at over a hundred top-tier hospitals in China, as well as frequently invited to give keynote speeches or surgical demonstrations at international conferences.

Professional Roles

Member of the National Health and Family Planning Commission Urological Endoscopy Diagnosis and Treatment Technology Expert Group, member of the National Physician Periodic Assessment Urological Expert Committee under the Health and Family Planning Commission, member of the Endoscopic and Minimally Invasive Urology Group of the Urology Branch of the Chinese Medical Association, member of the Urology Committee of the Chinese Medical Doctor Association's Standardized Resident Training, standing committee member of the Endoscopy Branch of the China Medical Promotion Association, and director of the Guo Yinglu Urology Development Foundation. Currently, he is an editorial board member of Translational Andrology and Urology (TAU), corresponding editorial board member of the Chinese Journal of Urology, and editorial board member of Modern Urology and the Journal of Urology (electronic version).

Return to Home